Government as the First Investor in Biopharmaceutical Innovation: Evidence From New Drug Approvals 2010–2019
www.ineteconomics.org/research/research-papers/government-as-the-first-investor-in-biopharmaceutical-innovation-evidence-from-new-drug-approvals-2010-2019
1 Users
0 Comments
6 Highlights
0 Notes
Tags
Top Highlights
It also demonstrates the limited mechanisms available for recognizing the value created by these early investments and ensuring appropriate public returns
Overall, NIH funding contributed to research associated with every new drug approved from 2010-2019, totaling $230 billion
This NIH funding also produced 22 thousand patents, which provided marketing exclusivity for 27 (8.6%) of the drugs approved 2010-2019.
356 drugs
Overall, NIH funding contributed to research associated with every new drug approved from 2010-2019, totaling $230 billion
Ready to highlight and find good content?
Glasp is a social web highlighter that people can highlight and organize quotes and thoughts from the web, and access other like-minded people’s learning.